HIGHLIGHTS
- who: Richard David Leslie from the The University of Utah, United States have published the research work: Editorial: Latent Autoimmune Diabetes in Adults (LADA), in the Journal: (JOURNAL) of 29/08/2022
- future: Bjorklund et_al having failed to show a beneficial effect in progression of LADA cases with high GADA levels using sitagliptin tested the feasibility of using intralymphatic GAD-alum given with oral vitamin D as therapy after 5 months using a limited number of cases the results were interesting and the study continues.
SUMMARY
This Article was submitted to . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.